Regulatory Services in United States of America
The American pharmaceutical industry is a highly globalized industry. The industry alone holds almost half of the global pharmaceutical market, with sales of drugs in the country making up 48% of the global market for pharmaceuticals as of 2019.
The GDP per capita in the United States is was estimated to be 65,116, U.S. dollars in 2019. The pharmaceutical market in the United States is on a solid incline. It is projected that by 2023, Americans would spend between $635 and $655 billion on medicine. This represents a solid 29.6 – 33.7% increase in expenditure compared to 2019. This will undoubtedly make it the country with the highest pharmaceutical expenditures.